| Tumor VEGF | Serum VEGF | ||||
---|---|---|---|---|---|---|
 | Number of cases | % positive cells [median (range)] | P | Number of cases | Serum level (pg/ml) [median (range)] | P |
Age | Â | Â | Â | Â | Â | Â |
   51–70 years | 40 | 65 (10–100) | 0.91 | 43 | 180.5 (30.8–768.4) | 0.11 |
   > 70 years | 22 | 65 (5–100) |  | 26 | 241.5 (22.7–953.5) |  |
Histotype | Â | Â | Â | Â | Â | Â |
   Ductal | 53 | 70 (5–100) |  | 56 | 189.9 (30.8–953.5) | 0.71 |
   Others | 9 | 50 (10–75) |  | 13 | 238.4 (22.7–456.8) |  |
Tumor size | Â | Â | Â | Â | Â | Â |
   ≤ 2 cm | 42 | 70 (10–100) | 0.09 | 49 | 193.6 (30.8–953.5) | 0.42 |
   > 2 cm | 20 | 47.5 (5–90) |  | 19 | 144.5 (22.7–561.0) |  |
Node status | Â | Â | Â | Â | Â | Â |
   Node-negative | 30 | 70 (15–95) | 0.22 | 34 | 204.4 (36.6–768.4) | 0.50 |
   Node-positive | 27 | 60 (5–100) |  | 25 | 144.5 (22.7–953.5) |  |
Grade | Â | Â | Â | Â | Â | Â |
   1–2 | 38 | 75 (10–100) | 0.05 | 40 | 183.7 (30.8–768.4) | 0.348 |
   3 | 11 | 35 (5–90) |  | 11 | 144.5 (36.3–953.5) |  |
Steroid status | Â | Â | Â | Â | Â | Â |
   ER-positive | 43 | 70 (10–95) | 0.05 | 47 | 187.0 (30.8–953.5) | 0.45 |
   ER-negative | 10 | 30 (5–90) |  | 10 | 270.8 (48.3–768.4) |  |
   PgR-positive | 31 | 65 (10–95) | 0.72 | 34 | 187.1 (30.8–953.5) | 0.70 |
   PgR-negative | 22 | 67.5 (5–95) |  | 23 | 193.6 (48.3–674.1) |  |